NANOBIOTIX Announces Launch of Global Follow-On Offering and a Concurrent Private Placement Along with the Removal of the EIB Cash Covenant

PARIS and CAMBRIDGE, Mass., Nov. 01, 2023 -- NANOBIOTIX , a late-clinical stage biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer,...

Related Keywords

Massachusetts ,United States ,Canada ,Cambridge ,Cambridgeshire ,United Kingdom ,Paris ,France General ,France ,New York ,Boston ,French ,Brandon Owens ,Ligia Vela Reid ,Nanobiotix Adss ,Pierre Louis Germain ,European Investment Bank ,Company Ordinary ,Leerink Partners ,Exchange Commission ,Jjdc Inc ,Nasdaq ,Company Executive Board ,Financial Services ,Investor Relations Department ,Communications Department ,French Financial Markets Authority Autorit ,Euronext ,Company Adss ,Syndicate Department ,Equity Syndicate Prospectus Department ,Hc Wainwright Co ,Equity Syndicate Department ,French Ministry Of Economy ,American Depositary Shares ,Ordinary Shares ,European Offering ,Johnson Innovation ,Securities Act ,Global Offering ,Placement Amount ,Regulatory Cap ,French Ministry ,Concurrent Private ,Guggenheim Securities ,French Commercial Code ,Concurrent Private Placement ,Nasdaq Global Select Market ,Executive Board ,Ordinary Share ,Milestone Prepayment Mechanism ,Preliminary Prospectus Supplement ,French Financial Markets Authority ,Des March ,New York City ,Ulysse Communication ,Private Securities Litigation Reform Act ,Annual Report ,French Monetary ,Financial Code ,European Economic Area ,Relevant Member State ,Prospectus Regulation ,Markets Act ,Financial Promotion ,